Cargando…

Giant Non-Functioning Pituitary Adenomas: Treatment Considerations

Giant pituitary adenomas are a subgroup of pituitary adenomas defined by a diameter greater than 4 cm, and they account for 5–14% of adenomas in surgical series. Because of their growth patterns and locations, often involving critical neurovascular structures, they represent a true surgical challeng...

Descripción completa

Detalles Bibliográficos
Autores principales: Solari, Domenico, Cavallo, Luigi Maria, Graziadio, Chiara, Corvino, Sergio, Bove, Ilaria, Esposito, Felice, Cappabianca, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497296/
https://www.ncbi.nlm.nih.gov/pubmed/36138992
http://dx.doi.org/10.3390/brainsci12091256
_version_ 1784794476621856768
author Solari, Domenico
Cavallo, Luigi Maria
Graziadio, Chiara
Corvino, Sergio
Bove, Ilaria
Esposito, Felice
Cappabianca, Paolo
author_facet Solari, Domenico
Cavallo, Luigi Maria
Graziadio, Chiara
Corvino, Sergio
Bove, Ilaria
Esposito, Felice
Cappabianca, Paolo
author_sort Solari, Domenico
collection PubMed
description Giant pituitary adenomas are a subgroup of pituitary adenomas defined by a diameter greater than 4 cm, and they account for 5–14% of adenomas in surgical series. Because of their growth patterns and locations, often involving critical neurovascular structures, they represent a true surgical challenge, and gross total resection is difficult to achieve. There is no consensus on the optimal surgical strategy for giant pituitary adenomas, and, often, integrated multi-staged treatment strategies have been considered. Transcranial or transsphenoidal approaches, alone or combined, according to tumor and patient features are the two main routes. Each of these strategies has pros and cons. The conventional transcranial approach has for a long time been considered the first choice for the removal of giant pituitary adenomas. Currently, with endoscopic techniques, it is also possible to remove lesions that involve the intradural compartment and the adjacent neurovascular structures with the use of extended approaches. Our policy for the management of these lesions is to adopt the endoscopic endonasal approach as the first choice unless the tumor presents significant intracranial extension that results in it being outside the visibility and maneuverability of the endoscopic endonasal route. In these latter cases, we agree that the transcranial approach is more appropriate. However, accurate preoperative evaluation and refined treatment plans for each patient are mandatory to define a proper strategy in order to achieve the most effective long-term result.
format Online
Article
Text
id pubmed-9497296
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94972962022-09-23 Giant Non-Functioning Pituitary Adenomas: Treatment Considerations Solari, Domenico Cavallo, Luigi Maria Graziadio, Chiara Corvino, Sergio Bove, Ilaria Esposito, Felice Cappabianca, Paolo Brain Sci Opinion Giant pituitary adenomas are a subgroup of pituitary adenomas defined by a diameter greater than 4 cm, and they account for 5–14% of adenomas in surgical series. Because of their growth patterns and locations, often involving critical neurovascular structures, they represent a true surgical challenge, and gross total resection is difficult to achieve. There is no consensus on the optimal surgical strategy for giant pituitary adenomas, and, often, integrated multi-staged treatment strategies have been considered. Transcranial or transsphenoidal approaches, alone or combined, according to tumor and patient features are the two main routes. Each of these strategies has pros and cons. The conventional transcranial approach has for a long time been considered the first choice for the removal of giant pituitary adenomas. Currently, with endoscopic techniques, it is also possible to remove lesions that involve the intradural compartment and the adjacent neurovascular structures with the use of extended approaches. Our policy for the management of these lesions is to adopt the endoscopic endonasal approach as the first choice unless the tumor presents significant intracranial extension that results in it being outside the visibility and maneuverability of the endoscopic endonasal route. In these latter cases, we agree that the transcranial approach is more appropriate. However, accurate preoperative evaluation and refined treatment plans for each patient are mandatory to define a proper strategy in order to achieve the most effective long-term result. MDPI 2022-09-16 /pmc/articles/PMC9497296/ /pubmed/36138992 http://dx.doi.org/10.3390/brainsci12091256 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Opinion
Solari, Domenico
Cavallo, Luigi Maria
Graziadio, Chiara
Corvino, Sergio
Bove, Ilaria
Esposito, Felice
Cappabianca, Paolo
Giant Non-Functioning Pituitary Adenomas: Treatment Considerations
title Giant Non-Functioning Pituitary Adenomas: Treatment Considerations
title_full Giant Non-Functioning Pituitary Adenomas: Treatment Considerations
title_fullStr Giant Non-Functioning Pituitary Adenomas: Treatment Considerations
title_full_unstemmed Giant Non-Functioning Pituitary Adenomas: Treatment Considerations
title_short Giant Non-Functioning Pituitary Adenomas: Treatment Considerations
title_sort giant non-functioning pituitary adenomas: treatment considerations
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497296/
https://www.ncbi.nlm.nih.gov/pubmed/36138992
http://dx.doi.org/10.3390/brainsci12091256
work_keys_str_mv AT solaridomenico giantnonfunctioningpituitaryadenomastreatmentconsiderations
AT cavalloluigimaria giantnonfunctioningpituitaryadenomastreatmentconsiderations
AT graziadiochiara giantnonfunctioningpituitaryadenomastreatmentconsiderations
AT corvinosergio giantnonfunctioningpituitaryadenomastreatmentconsiderations
AT boveilaria giantnonfunctioningpituitaryadenomastreatmentconsiderations
AT espositofelice giantnonfunctioningpituitaryadenomastreatmentconsiderations
AT cappabiancapaolo giantnonfunctioningpituitaryadenomastreatmentconsiderations